11 – 20 of 22
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Increased serum levels of tumour-associated trypsin inhibitor independently predict a poor prognosis in colorectal cancer patients.
(
- Contribution to journal › Article
- 2009
-
Mark
CYCLIN A1 MEDIATES DRUG-RESISTANT METASTATIC SPREAD OF PCA CELLS IN XENOGRAFTS IN VIVO
2009) 24th Annual Congress of the European Association of Urology In European Urology Supplements 8(4). p.343-343(
- Contribution to journal › Published meeting abstract
-
Mark
High expression of tumour-associated trypsin inhibitor correlates with liver metastasis and poor prognosis in colorectal cancer.
(
- Contribution to journal › Article
-
Mark
Cystatin C is downregulated in prostate cancer and modulates invasion of prostate cancer cells via MAPK/Erk and androgen receptor pathways.
(
- Contribution to journal › Article
- 2008
-
Mark
Multiple cellular mechanisms related to cyclin A1 in prostate cancer invasion and metastasis.
(
- Contribution to journal › Article
-
Mark
Interleukin-6 activates PI3K/Akt pathway and regulates cyclin A1 to promote prostate cancer cell survival
(
- Contribution to journal › Article
- 2005
-
Mark
A role for cyclin A1 in mediating the autocrine expression of vascular endothelial growth factor in prostate cancer.
(
- Contribution to journal › Article
-
Mark
Expression of tumor-associated trypsinogens (TAT-1 and TAT-2) in prostate cancer.
(
- Contribution to journal › Article
-
Mark
Expression and signaling activity of Wnt-5a/discoidin domain receptor-1 and Syk plays distinct but decisive roles in breast cancer patient survival
(
- Contribution to journal › Article
- 2004
-
Mark
Expression of serotonin receptors and role of serotonin in human prostate cancer tissue and cell lines.
(
- Contribution to journal › Article